• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease.

作者信息

Zou Zi-Yuan, Fan Jian-Gao

机构信息

Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.

Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai 200092, China.

出版信息

J Hepatol. 2020 Jul;73(1):214-216. doi: 10.1016/j.jhep.2020.03.003. Epub 2020 Mar 28.

DOI:10.1016/j.jhep.2020.03.003
PMID:32229037
Abstract
摘要

相似文献

1
Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者慢性肾病的发病率
J Hepatol. 2020 Jul;73(1):214-216. doi: 10.1016/j.jhep.2020.03.003. Epub 2020 Mar 28.
2
Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.慢性肾病患者中非酒精性脂肪性肝病的发病率及预测因素
Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046.
3
Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease.非酒精性脂肪性肝病：慢性肾脏病的一个危险因素。
Ann Hepatol. 2023 Sep-Oct;28(5):101122. doi: 10.1016/j.aohep.2023.101122. Epub 2023 Jun 2.
4
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?非酒精性脂肪性肝病与慢性肾脏病：肝脏硬度评估对肾脏有益？
Diabetes Metab. 2020 Sep;46(4):259-260. doi: 10.1016/j.diabet.2020.07.009. Epub 2020 Aug 1.
5
A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.慢性肾脏病和非酒精性脂肪性肝病发病率上升的简要综述。
Physiol Int. 2019 Dec 1;106(4):305-310.
6
Does diagnosing fatty liver and chronic kidney disease do more good than harm?诊断脂肪肝和慢性肾病是利大于弊吗？
PLoS Med. 2014 Jul 22;11(7):e1001681. doi: 10.1371/journal.pmed.1001681. eCollection 2014 Jul.
7
Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.非酒精性脂肪肝与新发慢性肾脏病无关：基于组织学的大规模健康个体对照研究
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):441-3. doi: 10.1097/MEG.0000000000000531.
8
Association between NAFLD and CKD and its effect on eGFR.非酒精性脂肪性肝病与慢性肾脏病之间的关联及其对估算肾小球滤过率的影响。
J Assoc Physicians India. 2020 Jan;68(1):75.
9
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的肝外并发症。
Clin Liver Dis. 2016 May;20(2):387-401. doi: 10.1016/j.cld.2015.10.004. Epub 2016 Feb 18.
10
Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.非酒精性脂肪性肝病增加了发生进展性慢性肾脏病的风险：一项倾向评分匹配队列研究。
J Intern Med. 2019 Dec;286(6):711-722. doi: 10.1111/joim.12964. Epub 2019 Aug 23.

引用本文的文献

1
RENAL INJURY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN PATIENTS WITH OBESITY.肥胖患者的肾损伤与代谢功能障碍相关脂肪性肝病
Arq Gastroenterol. 2025 May 2;62:e25008. doi: 10.1590/S0004-2803.24612025-008. eCollection 2025.
2
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD.针对胰岛素抵抗和肝纤维化：非酒精性脂肪性肝病相关慢性肾脏病的筛查重点
Biomedicines. 2025 Apr 1;13(4):842. doi: 10.3390/biomedicines13040842.
3
Higher risk of carotid plaque among lean individuals with non-alcoholic fatty liver disease: A retrospective study.
非酒精性脂肪性肝病的瘦人颈动脉斑块风险更高：一项回顾性研究。
PLoS One. 2025 Feb 3;20(2):e0316997. doi: 10.1371/journal.pone.0316997. eCollection 2025.
4
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南（2024年版）》
J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.
5
Effects of a High Trans Fatty Acid Diet on Kidney-, Liver-, and Heart-Associated Diseases in a Rabbit Model.高反式脂肪酸饮食对兔模型中肾脏、肝脏和心脏相关疾病的影响。
Metabolites. 2024 Aug 8;14(8):442. doi: 10.3390/metabo14080442.
6
Chronic kidney disease and the severity of non-alcoholic fatty liver disease: a systematic review.慢性肾脏病与非酒精性脂肪性肝病的严重程度：一项系统综述
Rev Assoc Med Bras (1992). 2023 Jul 17;69(7):e20221348. doi: 10.1590/1806-9282.20221348. eCollection 2023.
7
Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease.尿液蛋白质组在鉴别代谢相关脂肪性肝病患者肝脂肪变性中的作用
Diagnostics (Basel). 2022 Jun 7;12(6):1412. doi: 10.3390/diagnostics12061412.
8
Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.基于网络药理学和实验探究参芪丸治疗非酒精性脂肪性肝炎的作用机制和靶点。
J Immunol Res. 2022 Jun 12;2022:6588144. doi: 10.1155/2022/6588144. eCollection 2022.
9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease.非酒精性脂肪性肝病对慢性肾脏病发生及严重程度的影响
J Clin Transl Hepatol. 2022 Feb 28;10(1):164-173. doi: 10.14218/JCTH.2021.00171. Epub 2021 Sep 22.